The Kingdom’s leading economic zone will soon host a new Indian pharmaceutical manufacturing plant.
Phnom Penh, 20th November 2017 – A new long-term lease of land agreement has been signed between Phnom Penh SEZ Plc. and VTSIX GROUP on the 8th November to establish a WHO GMP compliant pharmaceutical manufacturing plant. The Indian company, VTSIX GROUP, is specialized in the production of oral pharmaceuticals, including tablets, capsules and syrups. The company brings its years-long expertise in the medical industry and will invest in the healthcare sector in Cambodia, hoping to produce up to 500 million units per year in the form of capsules, tablets or syrups - a solid output that will be reached by employing 25 well-trained and qualified workers.
Operations are to launch in 2018.
“We are glad to welcome a modern pharmaceutical company from India here in our international economic zone, and we will provide our full support to VTSIX GROUP to successfully launch and conduct their manufacturing here in Phnom Penh SEZ. We wish the company all success and prosperity on their Cambodia project, which in turn will help create more career opportunities for Cambodian people and promote the development of the country,” says Hiroshi Uematsu, Phnom Penh SEZ Plc. CEO.